Afshar-Oromieh A - Search Results

1

The clinical acceptability of short versus long duration acquisitions for head and neck cancer using long-axial field-of-view PET/CT: a retrospective evaluation.

Mei R, Pyka T, Sari H, Fanti S, Afshar-Oromieh A, Giger R, Caobelli F, Rominger A, Alberts I. Mei R, et al. Among authors: afshar oromieh a. Eur J Nucl Med Mol Imaging. 2024 Apr;51(5):1436-1443. doi: 10.1007/s00259-023-06516-6. Epub 2023 Dec 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 38095670 Free PMC article.

2

Imaging and radiotherapy for recurrent prostate cancer: An evolutionary partnership.

Murray JR, Kopka K, Afshar-Oromieh A. Murray JR, et al. Radiother Oncol. 2018 Nov;129(2):387-388. doi: 10.1016/j.radonc.2018.09.016. Epub 2018 Oct 15. Radiother Oncol. 2018. PMID: 30336957 No abstract available.

3

Impact of ¹⁸F-FET PET on Target Volume Definition and Tumor Progression of Recurrent High Grade Glioma Treated with Carbon-Ion Radiotherapy.

Debus C, Waltenberger M, Floca R, Afshar-Oromieh A, Bougatf N, Adeberg S, Heiland S, Bendszus M, Wick W, Rieken S, Haberkorn U, Debus J, Knoll M, Abdollahi A. Debus C, et al. Sci Rep. 2018 May 8;8(1):7201. doi: 10.1038/s41598-018-25350-7. Sci Rep. 2018. PMID: 29740097 Free PMC article.

4

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.

Afshar-Oromieh A, Zechmann CM, Malcher A, Eder M, Eisenhut M, Linhart HG, Holland-Letz T, Hadaschik BA, Giesel FL, Debus J, Haberkorn U. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2014 Jan;41(1):11-20. doi: 10.1007/s00259-013-2525-5. Epub 2013 Sep 27. Eur J Nucl Med Mol Imaging. 2014. PMID: 24072344 Free PMC article.

5

Comparison of PET/CT and PET/MRI hybrid systems using a 68Ga-labelled PSMA ligand for the diagnosis of recurrent prostate cancer: initial experience.

Afshar-Oromieh A, Haberkorn U, Schlemmer HP, Fenchel M, Eder M, Eisenhut M, Hadaschik BA, Kopp-Schneider A, Röthke M. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2014 May;41(5):887-97. doi: 10.1007/s00259-013-2660-z. Epub 2013 Dec 19. Eur J Nucl Med Mol Imaging. 2014. PMID: 24352789

6

PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancer.

Giesel FL, Fiedler H, Stefanova M, Sterzing F, Rius M, Kopka K, Moltz JH, Afshar-Oromieh A, Choyke PL, Haberkorn U, Kratochwil C. Giesel FL, et al. Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1794-800. doi: 10.1007/s00259-015-3106-6. Epub 2015 Jul 11. Eur J Nucl Med Mol Imaging. 2015. PMID: 26162799 Free PMC article.

7

Comparison of hybrid (68)Ga-PSMA PET/MRI and (68)Ga-PSMA PET/CT in the evaluation of lymph node and bone metastases of prostate cancer.

Freitag MT, Radtke JP, Hadaschik BA, Kopp-Schneider A, Eder M, Kopka K, Haberkorn U, Roethke M, Schlemmer HP, Afshar-Oromieh A. Freitag MT, et al. Eur J Nucl Med Mol Imaging. 2016 Jan;43(1):70-83. doi: 10.1007/s00259-015-3206-3. Epub 2015 Oct 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 26508290

8

Diagnostic performance of ⁶⁸Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients.

Afshar-Oromieh A, Holland-Letz T, Giesel FL, Kratochwil C, Mier W, Haufe S, Debus N, Eder M, Eisenhut M, Schäfer M, Neels O, Hohenfellner M, Kopka K, Kauczor HU, Debus J, Haberkorn U. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2017 Aug;44(8):1258-1268. doi: 10.1007/s00259-017-3711-7. Epub 2017 May 12. Eur J Nucl Med Mol Imaging. 2017. PMID: 28497198 Free PMC article.

9

Tracer uptake in mediastinal and paraaortal thoracic lymph nodes as a potential pitfall in image interpretation of PSMA ligand PET/CT.

Afshar-Oromieh A, Sattler LP, Steiger K, Holland-Letz T, da Cunha ML, Mier W, Neels O, Kopka K, Weichert W, Haberkorn U. Afshar-Oromieh A, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1179-1187. doi: 10.1007/s00259-018-3965-8. Epub 2018 Mar 1. Eur J Nucl Med Mol Imaging. 2018. PMID: 29497802 Free article.

10

¹⁸F-PSMA-1007 PET/CT at 60 and 120 minutes in patients with prostate cancer: biodistribution, tumour detection and activity kinetics.

Rahbar K, Afshar-Oromieh A, Bögemann M, Wagner S, Schäfers M, Stegger L, Weckesser M. Rahbar K, et al. Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1329-1334. doi: 10.1007/s00259-018-3989-0. Epub 2018 Mar 14. Eur J Nucl Med Mol Imaging. 2018. PMID: 29541812 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters